RUO peptide processing
RUO peptide payment processing is card acquiring for businesses that sell research-use-only peptides. PeptideApprove provides merchant services for that category and for other eligible high-risk ecommerce merchants, and is partnered with the acquiring bank. It qualifies the merchant and submits the documents. The acquiring bank and its processing partners settle the transactions. Pricing is confirmed after underwriting, not listed as a public percentage.
Last reviewed .
Mainstream ecommerce accounts are often a poor fit for RUO peptide catalogs. Merchants get through checkout setup and then lose the account, or they never get an answer about whether the category is allowed. A purpose-built review starts with the products and the website instead of treating peptides as ordinary supplements.
Research-peptide payment processing and high-risk payment processing for peptides are the same subject on this page. Separate doorway URLs for those phrases redirect here.
Eligibility is subject to underwriting. The review covers product category, website claims, ownership, and processing history. Compliant RUO retailers are not required to hold LegitScript for these merchant services. Healthcare models may be. No merchant is approved because it uses the words research use only.
See peptide merchant accounts, card processing and gateways, and the RUO glossary entry.
Yes. PeptideApprove provides merchant services for research-use-only peptide ecommerce and other eligible high-risk merchants. RUO is the category the public site is built around.
Research-use-only describes products sold for research, not as consumer medicines. Acquirers and sponsor banks still review the website, product claims, and business model. A research label does not by itself approve an account.
Research-use-only (RUO) is a labeling category for materials sold for research rather than as consumer or patient products. Payment partners still review how the site describes those products.
The glossary page on RUO explains why human-use claims create underwriting problems. PeptideApprove does not provide legal or regulatory advice about how a merchant should label products.
Card acquirers often treat peptide ecommerce as high risk because of product claims, regulatory attention, dispute rates, and the chance a mainstream processor will exit the category. That is a risk classification, not a statement that every peptide merchant will be declined.
High risk usually means tighter underwriting, possible reserves, and closer review of the website. It does not publish a single industry price, and PeptideApprove does not publish one either.
A peptide merchant account is the card account a peptide business uses to accept cards. PeptideApprove provides the merchant services for that account and is partnered with the acquiring bank that sponsors it.
The account, if approved, is governed by the merchant agreement, card-network rules, and the acquiring bank's requirements.
PeptideApprove reviews the merchant profile, then routes a complete file for sponsor-bank underwriting. The merchant is told what path fits, or if the file cannot be onboarded.
Eligible merchants with complete information can receive an underwriting response in about 48 hours. Card acceptance, if approved, is described as beginning within 72 hours after all documents are in. Both timings depend on review and are not a guarantee.
No LegitScript is required for compliant research-use-only retailers using PeptideApprove's merchant services. Clinical, pharmacy, telehealth, and patient-care models may require healthcare compliance credentials and are reviewed on a separate path.
That is how these merchant services are offered with the acquiring bank PeptideApprove is partnered with. It is not a claim about every bank or network. Merchants are still responsible for their own legal compliance. PeptideApprove does not provide legal advice.
Apply